Ling He | Cardiotoxicity | Best Research Article Award

Posted on by Pencis

Assoc. Prof. Dr. Ling He | Cardiotoxicity | Best Research Article Award

Assoc. Prof. Dr. Ling He, The Second Affiliated Hospital of Nanchang University, China

Assoc. Prof. Dr. Ling He is a distinguished medical professional at The Second Affiliated Hospital of Nanchang University, China. With a strong background in clinical medicine, she specializes in translational research, innovative diagnostics, and patient-centered care. As an associate professor, she actively mentors medical students and leads research projects focused on improving clinical outcomes and healthcare quality. Her work has been published in reputed journals and widely cited, reflecting her influence in the medical research community. Dr. He remains committed to advancing healthcare practices through academic excellence, collaborative research, and continuous medical innovation.

AUTHOR PROFILE

Scopus Profile

🧠 EARLY ACADEMIC PURSUITS:

Assoc. Prof. Dr. Ling He began her academic journey with a strong foundation in medical sciences, developing an early interest in clinical medicine and healthcare research. She pursued her undergraduate and postgraduate studies in prestigious medical institutions in China, eventually specializing in fields aligned with clinical diagnosis, treatment innovation, and patient-centric research. Her commitment to academic excellence and scientific rigor laid the groundwork for a promising career in medical academia and clinical research.

🩺 PROFESSIONAL ENDEAVORS:

Dr. Ling He currently serves as an Associate Professor at The Second Affiliated Hospital of Nanchang University, one of China’s reputed medical research and teaching hospitals. In her role, she is deeply involved in clinical practice, academic instruction, and mentoring young medical professionals. Her position also includes collaboration with multidisciplinary teams to improve healthcare delivery and treatment outcomes. Over the years, she has participated in numerous research projects, contributing both as a principal investigator and a collaborator.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOTOXICITY:

Dr. Ling He’s research spans a range of clinical and biomedical sciences, focusing on:

  • Translational medicine

  • Clinical treatment protocols and their effectiveness

  • Patient safety and quality improvement in hospitals

  • Innovative diagnostic techniques

  • Public health and epidemiological studies

Her studies aim to bridge the gap between laboratory research and bedside application, ensuring that the latest scientific discoveries translate into real-world clinical improvements.

🌍 IMPACT AND INFLUENCE:

Dr. Ling He has significantly influenced both her peers and students through her mentorship, research guidance, and active involvement in academic societies. Her work has contributed to:

  • Improved clinical outcomes

  • Refined patient management protocols

  • Enhanced medical education at Nanchang University

She is frequently invited to speak at conferences and seminars, where she shares her expertise on current medical challenges and innovations. Her contributions have also helped raise the global profile of The Second Affiliated Hospital of Nanchang University in academic circles.

📚 ACADEMIC CITES:

Dr. He’s research papers have been published in national and international journals, many of which are indexed in Scopus, Web of Science, and PubMed. Her work is often cited by researchers in:

  • Clinical medicine

  • Nursing

  • Hospital management

  • Public health

This scholarly attention showcases her relevance and credibility in the academic and clinical research community.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Assoc. Prof. Dr. Ling He is building a legacy as a thought leader in clinical medicine and hospital practice. Her future goals include:

  • Expanding international collaborations

  • Developing new models of patient-centered care

  • Training the next generation of clinicians and researchers

  • Publishing high-impact research in global medical journals

Her ongoing work is expected to shape healthcare policy, influence clinical education reforms, and enhance patient care standards both in China and beyond.

📝 OTHER IMPORTANT HIGHLIGHTS:

  • Active educator and mentor in Nanchang University’s clinical programs

  • Collaborative contributor to multi-hospital research networks

  • Advocate for innovation in healthcare systems

  • Works at the intersection of clinical practice and academic research

🌐CONCLUSION:

Assoc. Prof. Dr. Ling He stands as a dedicated and influential figure in clinical medicine and academic research. Through her role at The Second Affiliated Hospital of Nanchang University, she continues to bridge the gap between research and practice, contributing significantly to patient care and medical education. Her passion for innovation, mentorship, and collaboration is shaping the future of healthcare in China and beyond. As she advances in her career, Dr. He remains a beacon of inspiration for young professionals and a catalyst for positive change in the medical community.

TOP NOTABLE PUBLICATION

Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018

Authors: H. Lai, Y. Tu, C. Liao, L. He, J. Li

Journal: Cardiovascular Diabetology

Year: 2025

Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Posted on by Pencis

Prof. Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Prof. Zhihui Zhang, Army Medical University, China

Prof. Zhihui Zhang is a distinguished researcher at Army Medical University, China, specializing in cardiovascular diseases and stem cell therapy. His work focuses on endothelial seed cells, myocardial infarction, and immunosuppressive capabilities of mesenchymal stem cell-derived extracellular vesicles. He has published extensively in leading journals such as Genes and Diseases, Science Bulletin, and Stem Cell Research and Therapy. Prof. Zhang’s research contributes to advancing early diagnosis and targeted interventions for coronary microvascular dysfunction. His expertise in molecular biology and regenerative medicine has made significant impacts in cardiovascular research and clinical applications.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Zhihui Zhang embarked on his academic journey with a deep passion for cardiovascular medicine. His early education laid a strong foundation in medical sciences, leading him to specialize in cardiology. His dedication and excellence in research and clinical practice positioned him for advanced studies and significant contributions to the field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Zhang is the Director of the Department of Cardiology at the First Affiliated Hospital (Southwest Hospital) of the Army Medical University in Chongqing. His leadership extends beyond the hospital as he holds multiple prestigious roles:

  • Member of the Great Vessel Group under the Cardiology Branch of the Chinese Medical Association
  • Member of the Cardiologists’ Association of the Chinese Medical Doctor Association
  • Deputy Director of the Committee for Structural Heart Disease under the China Human Health Promotion Association
  • Deputy Director of the Cardiology Branch of the Chongqing Medical Association, leading the Interventional Cardiology and Imaging Group

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCH:

Dr. Zhang is renowned for his expertise in interventional treatment of coronary heart disease and structural heart disease. His research focuses on:

  • Precise diagnosis and treatment of coronary heart disease
  • Interventional therapy for valvular heart diseases
  • Establishing a cohort for precise classification of myocardial ischemia
  • Creating a biobank and an artificial intelligence center for coronary angiography physiological assessment

Additionally, he has developed the professional Circa Met DB database, specializing in metabolic circadian rhythms.

🌍IMPACT AND INFLUENCE:

Dr. Zhang’s contributions have earned him numerous accolades, including:
🏆 Two first prizes for scientific progress in Chongqing
🏆 One first prize for scientific progress in Hubei Province
🏆 One second prize for military medical achievements

He has successfully led over 20 research projects, ranging from national natural science funds to key military and Chongqing talent programs. His pioneering work in cardiology has influenced national and military healthcare policies.

📖ACADEMIC CITATIONS:

Dr. Zhang has an outstanding publication record, with more than 30 SCI papers as the first or corresponding author (including co-first/co-corresponding). His research has been featured in top-tier journals such as:
📌 The Lancet
📌 Nature Metabolism
📌 Nature Communications
📌 Trends in Cell Biology

Additionally, he has contributed to drafting and setting 12 expert consensus documents, served as a deputy editor for two monographs, and contributed to nine other books. His work extends to two national invention patents, further solidifying his impact in the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

As a recipient of the Outstanding Youth Talent Fund in National Defense Bioscience, Dr. Zhang is recognized as a key innovator in cardiology. He has been honored as an Innovation Leading Talent by the Chongqing Talents Program and as a Science and Technology Talent by the Army.

His legacy will continue to shape the future of cardiovascular medicine through:
✅ Advanced research in interventional cardiology
✅ Expansion of AI-driven medical diagnostics
✅ Development of groundbreaking therapeutic techniques
✅ Mentorship and training of future cardiologists

🌟CONCLUSION:

Prof. Zhihui Zhang is a visionary leader in cardiology, blending clinical excellence, groundbreaking research, and technological innovation. His contributions have not only transformed patient care but also advanced global medical knowledge. His work will undoubtedly influence generations of medical professionals and redefine the future of cardiovascular treatment.

TOP NOTABLE PUBLICATIONS

Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction

Authors: Dingyuan Tian, Jie Li, Qingyuan Yang, Zhihui Zhang, Fang Deng

Journal: Genes and Diseases

Year: 2025

Circadian nutrition: is meal timing an elixir for fatigue?

Authors: Zhihui Zhang, Lu Yan, Jonas T. Treebak, Min-Dian Li

Journal: Science Bulletin

Year: 2025

Foxo1 drives the TGFβ1-dependent dichotomy of Th17 cell fates

Authors: Mengjuan Zhang, Yude Guan, Meijuan Han, Xiaomin Zhang, Song Zhang

Journal: Journal of Leukocyte Biology

Year: 2025

The short-term outcomes and risk factors of post-myocardial infarction ventricular septal rupture: a multi-center retrospective study

Authors: Wenjian Luo, Li Wen, Jinning Zhang, Zhexue Qin, Shiyong Yu

Journal: Journal of Cardiothoracic Surgery

Year: 2024

Sources and applications of endothelial seed cells: a review

Authors: Dan Deng, Yu Zhang, Bo Tang, Zhihui Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis

Authors: Yanan Duan, Xiteng Chen, Hui Shao, Jiawei Wang, Xiaomin Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Authors: Junjie Tang, Yaoming Liu, Yinghao Wang, Ping Zhang, Rong Lu

Journal: Biomarker Research

Year: 2024

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001–2018

Authors: Diyu Cui, Chao Zhang, Yi Chen, Yu Zhang, Ping Zhu

Journal: Lipids in Health and Disease

Year: 2024

Single-cell transcriptomics enable the characterization of local extension in retinoblastoma

Authors: Yaoming Liu, Wei Hu, Yanjie Xie, Shengli Li, Rong Lu

Journal: Communications Biology

Year: 2024

Clinical characteristics of patients with moderate or severe valvular heart disease

Authors: Hao Gao, Yuzhu Lei, Haiyun Huang, Yanxiu Chen, Zhihui Zhang

Journal: Chinese Journal of Cardiology

Year: 2024